The FTC is suing 2 drug companies
Advertisement
The Federal Trade Commission is going after two drug companies for obstructing generic drug competition.
Advertisement
The FTC is suing Endo International and Allergan, according to a complaint filed in a California Federal court on Monday. Endo was down 5% on the news Monday afternoon, while Allergan was slightly up. Teva, which acquired Allergan's generics business, was down 3%.
This isn't the first time the FTC has gone after Endo and Allergan. In March 2016, the agency sued both companies for blocking access to cheaper versions of Opana ER and Lidoderm, drugs used to treat pain.
This is developing.
Markets Insider
Advertisement
Next StoryAdvertisement
US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
2 states where home prices are falling because there are too many houses and not enough buyers
A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
9 health benefits of drinking sugarcane juice in summer
10 benefits of incorporating almond oil into your daily diet
From heart health to detoxification: 10 reasons to eat beetroot
Why did a NASA spacecraft suddenly start talking gibberish after more than 45 years of operation? What fixed it?
ICICI Bank shares climb nearly 5% after Q4 earnings; mcap soars by ₹36,555.4 crore
